HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert L Coffman Selected Research

Nivolumab

1/2021A Phase Ib Open-Label, Multicenter Study of Inhaled DV281, a TLR9 Agonist, in Combination with Nivolumab in Patients with Advanced or Metastatic Non-small Cell Lung Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert L Coffman Research Topics

Disease

10Inflammation (Inflammations)
01/2021 - 02/2002
9Neoplasms (Cancer)
12/2019 - 05/2007
6Asthma (Bronchial Asthma)
01/2021 - 12/2005
6Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2011 - 10/2005
4Infections
01/2021 - 11/2002
3COVID-19
02/2021 - 11/2020
3Pneumonia (Pneumonitis)
06/2014 - 07/2006
3Eosinophilia
06/2014 - 07/2002
2Anthrax
01/2016 - 01/2016
2Autoimmune Diseases (Autoimmune Disease)
03/2011 - 06/2010
2Virus Diseases (Viral Diseases)
01/2009 - 05/2007
2Proteinuria
12/2007 - 03/2003
2Hypersensitivity (Allergy)
05/2007 - 01/2002
2Granuloma
12/2002 - 11/2002
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1Lung Neoplasms (Lung Cancer)
01/2019
1Melanoma (Melanoma, Malignant)
10/2018
1Squamous Cell Carcinoma of Head and Neck
01/2017
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2017
1Neoplasm Metastasis (Metastasis)
01/2017
1Carcinoma (Carcinomatosis)
11/2016
1Adenocarcinoma
11/2016
1Experimental Arthritis
12/2013
1Whooping Cough (Pertussis)
07/2011
1Diphtheria
07/2011
1Measles
07/2011
1Dermatitis
12/2010
1Skin Diseases (Skin Disease)
12/2010
1Bacterial Infections (Bacterial Infection)
10/2010
1Weight Loss (Weight Reduction)
09/2009
1Allergic Rhinitis
01/2009
1Lymphopenia (Lymphocytopenia)
09/2008
1Psoriasis (Pustulosis Palmaris et Plantaris)
06/2008
1Glomerulonephritis
12/2007
1Communicable Diseases (Infectious Diseases)
05/2007
1Respiratory Hypersensitivity
07/2006
1Colitis
03/2005
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2005
1Chagas Disease (American Trypanosomiasis)
04/2004
1Nephritis
03/2003
1Allergic Bronchopulmonary Aspergillosis
03/2003

Drug/Important Bio-Agent (IBA)

6AntigensIBA
11/2020 - 01/2002
6CPG-oligonucleotideIBA
01/2019 - 01/2005
5VaccinesIBA
11/2020 - 05/2007
51018 oligonucleotideIBA
06/2014 - 01/2005
5CytokinesIBA
06/2014 - 11/2002
4RNA (Ribonucleic Acid)IBA
10/2018 - 06/2008
4Interleukin-10 (Interleukin 10)IBA
03/2003 - 03/2002
3aluminum sulfate (alum)IBA
02/2021 - 11/2020
3Toll-Like Receptor 9IBA
01/2021 - 10/2018
3Toll-Like Receptor AgonistsIBA
01/2017 - 05/2007
3Nucleic AcidsIBA
12/2010 - 10/2005
2AZD1419IBA
01/2021 - 01/2018
2Neutralizing AntibodiesIBA
01/2021 - 01/2016
2DV281IBA
01/2021 - 01/2019
2OligonucleotidesIBA
12/2019 - 12/2005
2OligodeoxyribonucleotidesIBA
06/2014 - 05/2005
2AllergensIBA
06/2014 - 12/2005
2Interleukin-4 (Interleukin 4)IBA
06/2014 - 07/2002
2Antigen-Antibody Complex (Immune Complex)IBA
03/2011 - 06/2008
2DNA (Deoxyribonucleic Acid)IBA
12/2010 - 06/2008
2LigandsIBA
10/2008 - 10/2005
2Interferon-alpha (Interferon Alfa)IBA
10/2008 - 01/2005
2AutoantibodiesIBA
12/2007 - 03/2003
2Toll-Like Receptors (Toll-Like Receptor)IBA
05/2007 - 10/2005
2Messenger RNA (mRNA)IBA
11/2002 - 07/2002
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2021
1NivolumabIBA
01/2021
1Subunit VaccinesIBA
11/2020
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2019
1Programmed Cell Death 1 ReceptorIBA
01/2019
1pembrolizumabIBA
10/2018
1Immune Checkpoint InhibitorsIBA
10/2018
1Complement System Proteins (Complement)IBA
01/2018
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2017
1theasinensin AIBA
11/2016
1FicollIBA
01/2016
1anthrax toxin (anthrax lethal factor)IBA
01/2016
1Toll-Like Receptor 8IBA
12/2013
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
03/2011
1GlucocorticoidsIBA
06/2010
1Toll-Like Receptor 7IBA
10/2008
1Interferon Type IIBA
10/2008
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2008
1Protein Subunit VaccinesIBA
09/2008
1Vaccine AdjuvantsIBA
09/2008
1Peptides (Polypeptides)IBA
06/2008
1Immunoglobulin E (IgE)IBA
12/2005
1InterferonsIBA
10/2005
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
03/2005
1Transforming Growth Factor beta (TGF-beta)IBA
03/2005
1Transforming Growth Factor beta1 (TGF beta 1)IBA
03/2005
1Rituximab (Mabthera)FDA Link
01/2005
1Chemokine CXCL12IBA
03/2003
1ChemokinesIBA
03/2003
1AntibodiesIBA
03/2003
1SmokeIBA
03/2003

Therapy/Procedure

5Therapeutics
12/2019 - 06/2014
4Immunotherapy
01/2019 - 11/2002
2Injections
10/2018 - 09/2008